Department of Obstetrics and Gynecology, Reproductive Medicine Centre, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Department of Obstetrics and Gynecology, Guangdong Provincial Clinical Research Center for Obstetrical and Gynecological Diseases, Guangzhou, China.
Front Endocrinol (Lausanne). 2024 May 28;15:1348771. doi: 10.3389/fendo.2024.1348771. eCollection 2024.
Ovarian stimulation (OS) for fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in women with PCOS often results in multiple follicular development, yet some individuals experience poor or suboptimal responses. Limited data exist regarding the impact of poor/suboptimal ovarian response on pregnancy outcomes in women with PCOS.
The aim of this study was to evaluate whether the live birth rate (LBR) per fresh embryo transfer and cumulative live birth rate (CLBR) per aspiration cycle differ in women with PCOS defined by the Patient-Oriented Strategy Encompassing IndividualizeD Oocyte Number (POSEIDON) criteria.
A retrospective study involving 2,377 women with PCOS who underwent their first IVF/ICSI cycle at Sun Yat-sen Memorial Hospital from January 2011 to December 2020 was used. Patients were categorized into four groups based on age, antral follicle count, and the number of oocytes retrieved, according to the POSEIDON criteria. The LBR and CLBR were compared among these groups. Logistic regression analysis was performed to assess whether the POSEIDON criteria served as independent risk factors and identify factors associated with POSEIDON.
For patients <35 years old, there was no significant difference in the clinical pregnancy rate between POSEIDON and non-POSEIDON patients, whereas POSEIDON patients exhibited lower rates of implantation and live birth. POSEIDON Group 1a displayed lower rates of implantation, clinical pregnancy, and live birth. However, no significant differences were observed in the rates of clinical pregnancy and live birth between POSEIDON Group 1b and non-POSEIDON groups. For patients ≥35 years old, there were no significant differences in the rates of implantation, clinical pregnancy, and live birth between POSEIDON and non-POSEIDON patients. CLBRs were significantly lower in POSEIDON Groups 1 and 2, compared with the non-POSEIDON groups. The levels of body mass index (BMI), follicle-stimulating hormone (FSH), and antral follicle count (AFC) were associated with POSEIDON hypo-response. POSEIDON was found to be associated with lower CLBR, but not LBR per fresh embryo transfer.
In patients with PCOS, an unexpected suboptimal response can achieve a fair LBR per fresh embryo transfer. However, CLBR per aspirated cycle in POSEIDON patients was lower than that of normal responders. BMI, basal FSH level, and AFC were independent factors associated with POSEIDON. Our study provides data for decision-making in women with PCOS after an unexpected poor/suboptimal response to OS.
多囊卵巢综合征(PCOS)患者进行体外受精(IVF)/卵胞浆内单精子注射(ICSI)的卵巢刺激(OS)通常会导致多个卵泡发育,但有些患者的反应较差或不理想。关于 PCOS 患者卵巢反应不良对妊娠结局的影响,数据有限。
本研究旨在评估根据患者导向的涵盖个体化卵母细胞数的策略(POSEIDON)标准定义的 PCOS 患者的新鲜胚胎移植活产率(LBR)和每个抽吸周期的累积活产率(CLBR)是否不同。
本回顾性研究纳入了 2011 年 1 月至 2020 年 12 月在中山大学孙逸仙纪念医院接受首次 IVF/ICSI 周期的 2377 名 PCOS 患者。根据 POSEIDON 标准,根据患者年龄、窦卵泡计数和获卵数将患者分为四组。比较这些组之间的 LBR 和 CLBR。采用 logistic 回归分析评估 POSEIDON 标准是否为独立危险因素,并确定与 POSEIDON 相关的因素。
对于<35 岁的患者,POSEIDON 患者与非 POSEIDON 患者的临床妊娠率无显著差异,而 POSEIDON 患者的种植率和活产率较低。POSEIDON 组 1a 的种植率、临床妊娠率和活产率较低。然而,POSEIDON 组 1b 与非 POSEIDON 组之间的临床妊娠率和活产率无显著差异。对于≥35 岁的患者,POSEIDON 患者与非 POSEIDON 患者的种植率、临床妊娠率和活产率无显著差异。POSEIDON 组 1 和 2 的 CLBR 明显低于非 POSEIDON 组。体质指数(BMI)、卵泡刺激素(FSH)和窦卵泡计数(AFC)水平与 POSEIDON 低反应相关。POSEIDON 与较低的 CLBR 相关,但与新鲜胚胎移植的 LBR 无关。
在 PCOS 患者中,意外的低反应仍可实现每新鲜胚胎移植的公平活产率。然而,POSEIDON 患者的每个抽吸周期的 CLBR 低于正常反应者。BMI、基础 FSH 水平和 AFC 是与 POSEIDON 相关的独立因素。我们的研究为意外卵巢反应不良或不理想的 PCOS 患者提供了决策数据。